Biomed Realty Trust (BMR) Misses Q4 FFO by 1c

Go back to Biomed Realty Trust (BMR) Misses Q4 FFO by 1c

Stifel Downgrades BioMed Realty (BMR) to Hold

February 9, 2015 6:38 AM EST

Stifel downgraded BioMed Realty (NYSE: BMR) from Buy to Hold and removed its price target (prior $23.00).

For an analyst ratings summary and ratings history on BioMed Realty click here. For more ratings news on BioMed Realty click here.

Shares of BioMed Realty closed at $22.88 yesterday.

... More

Mizuho Securities Upgrades BioMed Realty (BMR) to Neutral

February 6, 2015 6:46 AM EST

Mizuho Securities upgraded BioMed Realty (NYSE: BMR) from Outperform to Neutral with a price target of $23.00 (from $24.00).

For an analyst ratings summary and ratings history on BioMed Realty click here. For more ratings news on BioMed Realty click here.

Shares of BioMed Realty closed at $23.76 yesterday.

... More